AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7412158
Drug: Acetazolamide (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (oral medication)
Trial: 30338823
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (3-4 courses of cisplatin, ifosfamide, and adriamycin)
Trial: 24280811
Drug: Palonosetron-dexamethasone combination
RxNorm normalized name: palonosetron, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron-dexamethasone combination (0.075 mg palonosetron and 8 mg dexamethasone)
Trial: 22710099
Drug: Diet supplementation
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet supplementation with olive leaves (10 g/kg)
Trial: 22710099
Drug: Diet supplementation
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet supplementation with α‐tocopheryl acetate (200 mg/kg)
Trial: 2206836
Drug: diclofenac gel
RxNorm normalized name: diclofenac Topical Gel
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: diclofenac gel (Voltarol Emulgel) 4 g tds
Trial: 2206836
Drug: felbinac gel
RxNorm normalized name: felbinac
DrugBank: Felbinac (DB07477)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felbinac gel (Traxam) 4 g tds
Trial: 6108335
Drug: Ketazolam (once-daily)
DrugBank: Ketazolam (DB01587)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketazolam (once-daily)
Trial: 6108335
Drug: Ketazolam (three-times-daily)
RxNorm normalized name: bupropion
DrugBank: Ketazolam (DB01587)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketazolam (three-times-daily)
Trial: 23049924
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate treatment
Trial: 23049924
Drug: Folinate rescue
RxNorm normalized name: Folixate
DrugBank: Levomefolic acid (DB11256)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folinate rescue therapy
Trial: 16988651
Drug: Arabinoxylan (AX)
RxNorm normalized name: AX
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arabinoxylan (AX) supplement 15 g
Trial: 16269401
Drug: ASA 150
RxNorm normalized name: ASA 150 MG Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 150 mg daily and Low Molecular Weight Heparin (LMWH) 5000 IU x2 for three days
Trial: 16269401
Drug: Acetyl salicylic
RxNorm normalized name: Acetyl salicylic acid specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl salicylic acid (ASA) 150 mg daily
Trial: 14675849
Drug: New drug
RxNorm normalized name: varicella zoster immune globulin (Investigational New Drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drug treatment
Trial: 10520100
Drug: Subcutaneous patient‐controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous patient‐controlled analgesia (PCA) (bolus dose 2.5 mg diamorphine in 1 ml with a 20‐minute lockout)
Trial: 10520100
Drug: Intravenous patient‐controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient‐controlled analgesia (PCA) (bolus dose 0.5 mg diamorphine in 1 ml with a 5‐minute lockout)
Trial: 23248037
Drug: Pregabalin (PGB)
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin (PGB) add-on therapy
Trial: 18087553
Drug: Enalapril 10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10.0 mg/d
Trial: 18087553
Drug: Enalapril 10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10.0 mg + Folic acid 0.4 mg/d
Trial: 18087553
Drug: Enalapril 10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10.0 mg + Folic acid 0.8 mg/d
Trial: 15824681
Drug: High-dose epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose epinephrine (HDE) 0.1 mg/kg for initial dose and 0.2 mg/kg for subsequent doses
Trial: 15824681
Drug: Standard-dose epinephrine
RxNorm normalized name: epinephrine Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose epinephrine (SDE) 0.01 mg/kg
Trial: 7990367
Drug: Microwave resonance
RxNorm normalized name: benzocaine
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microwave resonance treatment (MRT)
Trial: 16160626
Drug: Paroxetine (PAR)
DrugBank: Paroxetine (DB00715)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paroxetine (PAR) up to 40 mg daily
Trial: 16160626
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR (VEN-XR) up to 225 mg daily
Trial: 8314541
Drug: Platinum-based chemotherapy
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum-based chemotherapy and radiotherapy
Trial: 3303886
Drug: Diltiazem (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (90 mg every 6 hours)
Trial: 31558624
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg daily oral sustained-release morphine
Trial: 29995672
Drug: Histamine H2
RxNorm normalized name: Histamine H2 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine H2 receptor blockers (H2RBs)
Trial: 1748229
Drug: Aspirin +
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin + dipyridamole (225 mg/day)
Trial: 6847332
Drug: Drug counseling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug counseling alone
Trial: 23464577
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin desensitization (100 mg daily)
Trial: 19918203
Drug: Raloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (60 mg daily for 12 months)
Trial: 18976766
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no drugs for 12 months)
Trial: 15152709
Drug: Peer Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer Group Therapy
Trial: 7942049
Drug: Alpha-tocopherol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-tocopherol (400 I.U. d‐1) and ascorbic acid (200 mg d‐1) supplementation
Trial: 3263876
Drug: Fluoxetine 40
RxNorm normalized name: fluoxetine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 40 mg daily
Trial: 3263876
Drug: Fluoxetine 60-80
RxNorm normalized name: fluoxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 60-80 mg daily
Trial: 3263876
Drug: Amitriptyline 100
RxNorm normalized name: amitriptyline 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 100 mg daily
Trial: 3263876
Drug: Amitriptyline 150-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 150-200 mg daily
Trial: 31797437
Drug: Surgical excision,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical excision, carbon dioxide (CO2) laser therapy, and triamcinolone acetonide (TAC) intralesional injections during surgery and follow-up.
Trial: 21486976
Drug: IM20 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM20 × 3 (standard dose, 20 μg)
Trial: 21486976
Drug: IM40 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM40 × 4 (double doses, 40 μg)
Trial: 21486976
Drug: ID4 ×
RxNorm normalized name: Idarubicin hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID4 × 4 (low doses, 4 μg)
Trial: 18392831
Drug: Ultravist 300
RxNorm normalized name: Ultravist 300mg I/ml Solution for Injection
DrugBank: Iopromide (DB09156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultravist 300 (300 mg iodine/ml) at a flow rate of 4.9 ml/s, 148 ml
Trial: 18392831
Drug: Ultravist 370
RxNorm normalized name: Ultravist 370mg I/ml Solution for Injection
DrugBank: Iopromide (DB09156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultravist 370 (370 mg iodine/ml) at a flow rate of 4.0 ml/s, 120 ml
Trial: 12931764
Drug: Toothbrush B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toothbrush B (Braun Oral B) activated
Trial: 8511445
Drug: Placebo-controlled vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-controlled vaccine
Trial: 18035098
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate 160 mg daily for 26 weeks
Trial: 16186437
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with aspirin
Trial: 16186437
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment plus colchicine 1.0 to 2.0 mg for the first day and then 0.5 to 1.0 mg/d for 3 months
Trial: 11715489
Drug: GLN group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLN group (glutamine dipeptide enriched enteral nutrition at 0.5 g.kg‐1.day‐1)
Trial: 2316233
Drug: Aluminum hydroxide
RxNorm normalized name: Aluminum Hydroxide
DrugBank: Aluminum hydroxide (DB06723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum hydroxide gel (30 mL) with quinidine gluconate (648 mg)
Trial: 2316233
Drug: Quinidine gluconate
RxNorm normalized name: Quinidine Gluconate
DrugBank: Quinidine (DB00908)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinidine gluconate (648 mg) without aluminum hydroxide gel
Trial: 30630371
Drug: Captopril +
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril + Metformin
Trial: 29960288
Drug: Tiaoshen Kaiqiao
RxNorm normalized name: MENTHOL 3 g TRANSDERMAL PATCH [TIANHE GUBEN YAOSHEN TIE GAO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiaoshen Kaiqiao acupuncture therapy and placebo starch tablets treatment
Trial: 29960288
Drug: Fluoxetine tablets
RxNorm normalized name: Fluoxetine Tablets
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine tablets and body acupuncture treatment
Trial: 29960288
Drug: Tiaoshen Kaiqiao
RxNorm normalized name: MENTHOL 3 g TRANSDERMAL PATCH [TIANHE GUBEN YAOSHEN TIE GAO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiaoshen Kaiqiao acupuncture therapy
Trial: 25466703
Drug: Nicotine (6‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (6‐mg gum) + MAO‐A inhibition (moclobemide 75 mg)
Trial: 25466703
Drug: Nicotine (6‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (6‐mg gum)
Trial: 7871062
Drug: Melatonin 20
RxNorm normalized name: melatonin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 20 mg
Trial: 11464450
Drug: Eprosartan (400-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan (400-800 mg) alone or in combination with hydrochlorothiazide (HCTZ)
Trial: 29095245
Drug: Intra-articular Steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular Steroid (IAS) injection
Trial: 28783858
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine group (n=48)
Trial: 26355928
Drug: Sulodexide (Vessel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulodexide (Vessel Due F) treatment for 50 days
Trial: 26355928
Drug: Sulodexide (Vessel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulodexide (Vessel Due F) treatment
Trial: 21128816
Drug: Metformin (M)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (M) plus Levothyroxine (L‐T₄)
Trial: 21128816
Drug: Levothyroxine (L‐T₄)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levothyroxine (L‐T₄)
Trial: 17641893
Drug: Capecitabine 628
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 628 mg/m² b.i.d. plus paclitaxel 80 mg/m²
Trial: 17641893
Drug: Capecitabine 829
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 829 mg/m² b.i.d. plus paclitaxel 80 mg/m²
Trial: 15746509
Drug: Nonpharmacologic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpharmacologic therapies
Trial: 15746509
Drug: Pharmacologic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic therapies
Trial: 12911181
Drug: High-dose albuterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose albuterol (HDA)
Trial: 8546472
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy (400 mg UFT therapy daily for 10 days)
Trial: 2070704
Drug: Maalox TC
RxNorm normalized name: Aluminum Hydroxide/Magnesium Hydroxide 225 MG/5 ML-200 MG/5 ML Oral Suspension [MAALOX TC]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox TC (three tablets four times daily)
Trial: 31393353
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy with cognitive-behavioral therapy (MTCBP) for 12 weeks
Trial: 31393353
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy with cognitive-behavioral therapy (MTCBP)
Trial: 30334434
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of oral probiotics, dosage and duration not specified
Trial: 27736051
Drug: N-Acetylcysteine (2,400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-Acetylcysteine (2,400 mg/d)
Trial: 27736051
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus cognitive-behavioral therapy for SUD
Trial: 20642198
Drug: Self-management education
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management education (contract to adopt behavior, workbook, weekly reinforcements for 12 weeks, frequent follow-up visits)
Trial: 17661935
Drug: HA gel
RxNorm normalized name: Neevo DHA Gelcap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA gel
Trial: 17661935
Drug: hylan B
RxNorm normalized name: hylan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hylan B plus gel
Trial: 10718074
Drug: Control +
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control + caffeine (Cc)
Trial: 9196163
Drug: ACTH 2
RxNorm normalized name: ACTH
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACTH 2 mg plus 1 mg on day 4
Trial: 9196163
Drug: ACTH 1
RxNorm normalized name: adrenocorticotropin (ACTH 1-18),I-125 (TYR)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACTH 1 mg
Trial: 1546123
Drug: Moclobemide (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (450 mg/day, reduced to 300 mg/day after 4 weeks if required)
Trial: 1546123
Drug: Amineptine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amineptine (200 mg/day, reduced to 100 mg/day after 4 weeks if required)
Trial: 2864663
Drug: Intensive antacid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive antacid and thrombin
Trial: 26289613
Drug: eHealth intervention
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eHealth intervention (monthly teleassistance)
Trial: 15927063
Drug: Single inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single inhalation of hyaluronic acid
Trial: 10340882
Drug: Breast-Conservation Therapy
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast-Conservation Therapy (BCT)
Trial: 7488812
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for 6 months (protocol C)
Trial: 7488812
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for 2 months (protocol B)
Trial: 7488812
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for 3 months (protocol A)
Trial: 1928875
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (AC) administered 15 minutes after acetaminophen
Trial: 1928875
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (AC) administered 30 minutes after acetaminophen
Trial: 1928875
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (AC) administered 120 minutes after acetaminophen
Trial: 6869761
Drug: Rapid infusion
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid infusion of etomidate
Trial: 6869761
Drug: Thiopentone bolus
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone bolus injection
Trial: 27183545
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide (FAc) 0.5 µg/day
Trial: 27183545
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide (FAc) 0.2 µg/day
Trial: 24346280
Drug: Lapatinib administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib administered 1 h after a low-fat meal
Trial: 24346280
Drug: Lapatinib administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib administered 1 h after a high-fat meal
Trial: 24346280
Drug: Lapatinib administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib administered 1 h before a low-fat meal
Trial: 22041970
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration solution (ORS) group
Trial: 16636870
Drug: Clazosentan 30
RxNorm normalized name: clazosentan
DrugBank: Clazosentan (DB06677)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clazosentan 30 mg/h for 3 h
Trial: 16636870
Drug: Clazosentan 60
RxNorm normalized name: clazosentan
DrugBank: Clazosentan (DB06677)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clazosentan 60 mg/h for 6 h
Trial: 16636870
Drug: Clazosentan 30
RxNorm normalized name: clazosentan
DrugBank: Clazosentan (DB06677)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clazosentan 30 mg/h for 12 h
Trial: 16636870
Drug: Clazosentan 10
RxNorm normalized name: clazosentan
DrugBank: Clazosentan (DB06677)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clazosentan 10 mg/h for 3 h
Trial: 16636870
Drug: Clazosentan infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clazosentan infusion
Trial: 16135178
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (400 microg/puff, twice daily)
Trial: 8636714
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha 2a (IFN) treatment
Trial: 2483687
Drug: Methylprednisolone sodium
RxNorm normalized name: methylPREDNISolone sodium phosphate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone sodium succinate 125 mg daily infusions
Trial: 61439
Drug: Methyldopa ('Aldomet')
RxNorm normalized name: Methyldopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methyldopa ('Aldomet') treatment
Trial: 28969327
Drug: Deep NMB
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep NMB (infusion of rocuronium 2 mg ml -1)
Trial: 28969327
Drug: Standard NMB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard NMB (bolus of rocuronium 10 mg or increased depth of anaesthesia)
Trial: 26255515
Drug: Auricular point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular point sticking therapy (stimulated on specific points once a week for 4 weeks)
Trial: 26255515
Drug: Combined program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined program of auricular point sticking therapy and TCM psychotherapy (4 weeks treatment)
Trial: 26255515
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication group (oral administration of deanxit, one tablet a day for 4 weeks)
Trial: 23153291
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with wavelength 830 nm, dose of 2 J/cm² and additional spots of 1 J/cm².
Trial: 23153291
Drug: Placebo light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo light treatment (control group).